Cholangiocarcinoma: the quest for a second-line systemic treatment

por Vienot, Angélique, Neuzillet, Cindy
Publicado 2019

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?

por Hilmi, Marc, Bartholin, Laurent, Neuzillet, Cindy
Publicado 2018

Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study proto...

por Neuzillet, Cindy, Vergnault, Mathieu, Bonnetain, Franck, Hammel, Pascal
Publicado 2015

Immune Therapy for Liver Cancers

por Hilmi, Marc, Vienot, Angélique, Rousseau, Benoît, Neuzillet, Cindy
Publicado 2019

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion

por Hilmi, Marc, Nicolle, Rémy, Bousquet, Corinne, Neuzillet, Cindy
Publicado 2020

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis

por Neuzillet, Cindy, Emery, Corinne, Teissier, Clément, Bouée, Stéphane, Lièvre, Astrid
Publicado 2022

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?

por Boilève, Alice, Hilmi, Marc, Delaye, Matthieu, Tijeras-Raballand, Annemilaï, Neuzillet, Cindy
Publicado 2021

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis

por de Mestier, Louis, Neuzillet, Cindy, Hentic, Olivia, Kianmanesh, Reza, Hammel, Pascal, Ruszniewski, Philippe
Publicado 2012

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

por Hilmi, Marc, Neuzillet, Cindy, Calderaro, Julien, Lafdil, Fouad, Pawlotsky, Jean-Michel, Rousseau, Benoit
Publicado 2019

Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives

por Torregrosa, Cécile, Chorin, Frédéric, Beltran, Eva Ester Molina, Neuzillet, Cindy, Cardot-Ruffino, Victoire
Publicado 2022

Targeting cancer cell metabolism in pancreatic adenocarcinoma

por Cohen, Romain, Neuzillet, Cindy, Tijeras-Raballand, Annemilaï, Faivre, Sandrine, de Gramont, Armand, Raymond, Eric
Publicado 2015

Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National Survey

por Hilmi, Marc, Boilève, Alice, Ducousso, Anabelle, Michalet, Morgan, Turpin, Anthony, Neuzillet, Cindy, Naoun, Natacha
Publicado 2020

Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma

por Neuzillet, Cindy, Babai, Samy, Kempf, Emmanuelle, Pujol, Géraldine, Rousseau, Benoît, Le-Louët, Hervé, Christophe Tournigand
Publicado 2016

Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas

por Neuzillet, Cindy, de Gramont, Armand, Tijeras-Raballand, Annemilaï, de Mestier, Louis, Cros, Jérome, Faivre, Sandrine, Raymond, Eric
Publicado 2013

Pancreatic cancer orthotopic graft in a murine model

por Muzzolini, Milena, Belhabib, Ismahane, Cardot, Victoire, Tijeras-Raballand, Annemilaï, Neuzillet, Cindy, Bousquet, Corinne, Lupinacci, Renato Micelli, Jean, Christine
Publicado 2023

Optimizing Patient Pathways in Advanced Biliary Tract Cancers: Recent Advances and a French Perspective

por Neuzillet, Cindy, Artru, Pascal, Assenat, Eric, Edeline, Julien, Adhoute, Xavier, Sabourin, Jean-Christophe, Turpin, Anthony, Coriat, Romain, Malka, David
Publicado 2023

The Immune Landscape of Human Pancreatic Ductal Carcinoma: Key Players, Clinical Implications, and Challenges

por Muller, Marie, Haghnejad, Vincent, Schaefer, Marion, Gauchotte, Guillaume, Caron, Bénédicte, Peyrin-Biroulet, Laurent, Bronowicki, Jean-Pierre, Neuzillet, Cindy, Lopez, Anthony
Publicado 2022

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies

por Turpin, Anthony, Neuzillet, Cindy, Colle, Elise, Dusetti, Nelson, Nicolle, Rémy, Cros, Jérôme, de Mestier, Louis, Bachet, Jean-Baptiste, Hammel, Pascal
Publicado 2022

Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors

por Hammel, Pascal, Vitellius, Carole, Boisteau, Émeric, Wisniewski, Mathilde, Colle, Elise, Hilmi, Marc, Dengremont, Christelle, Granier, Sandra, Turpin, Anthony, de Mestier, Louis, Neuzillet, Cindy
Publicado 2020

Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients

por Serova, Maria, Tijeras-Raballand, Annemilaï, Santos, Célia Dos, Albuquerque, Miguel, Paradis, Valerie, Neuzillet, Cindy, Benhadji, Karim A., Raymond, Eric, Faivre, Sandrine, de Gramont, Armand
Publicado 2015